The Food and Drug Administration (FDA) is seeking public feedback on a proposed information collection related to the regulation of blood and blood components. This initiative, required by the Paperwork Reduction Act of 1995, involves guidelines for good manufacturing practices, donation testing, donor notification, and procedures for tracking potentially tainted blood ("lookback"). The FDA is interested in comments on the necessity and usefulness of the data collection, the accuracy of its burden estimates, and potential improvements to reduce respondent burdens. Stakeholders have until April 23, 2021, to submit their responses to the proposal.
Simple Explanation
The FDA wants people to share their thoughts on how blood donations are tested and monitored to make sure they're safe, and everyone has until April 23, 2021, to give their ideas. They're checking to see if the current rules are good enough and if there's a better way to gather the information they need.